Description
Glifempa-M 25/500mg Tablets (30’s)
Glifempa-M 25/500mg is a fixed-dose combination of Empagliflozin 25mg and Metformin Hydrochloride 500mg, used for the effective treatment of type 2 diabetes mellitus. This dual-action therapy targets high blood sugar through complementary mechanisms.
Key Features:
-
Empagliflozin (25mg) – An SGLT2 inhibitor that lowers blood glucose by promoting glucose excretion through urine.
-
Metformin (500mg) – A biguanide that decreases liver glucose production and improves insulin sensitivity.
-
Dual mechanism of action for better glycemic control.
-
May support weight loss and reduce the risk of cardiovascular and kidney complications.
-
Convenient oral tablet format for daily use.
Indications:
-
For adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
-
Recommended when monotherapy with Metformin or Empagliflozin does not provide adequate glycemic control.
Dosage & Administration:
-
Usually taken once or twice daily with meals to minimize gastrointestinal discomfort.
-
Dosage should be individualized based on glycemic response and renal function.
-
Regular blood glucose and kidney function monitoring is essential.
Precautions:
-
Not suitable for type 1 diabetes or diabetic ketoacidosis.
-
Use with caution in renal or hepatic impairment.
-
Monitor for signs of lactic acidosis, dehydration, or urinary/genital infections.
-
Avoid excessive alcohol consumption.
Possible Side Effects:
-
Gastrointestinal upset (nausea, diarrhea) – mainly due to Metformin
-
Urinary or genital infections
-
Increased urination, mild dehydration
-
Rare but serious: Lactic acidosis, ketoacidosis
Storage:
-
Store in a cool, dry place below 25°C.
-
Keep out of reach of children.
Reviews
There are no reviews yet.